Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
516.9 USD | -0.86% | -5.28% | +9.59% |
May. 15 | Transcript : Elevance Health, Inc. - Shareholder/Analyst Call | |
May. 02 | Factbox-Biggest cyber attacks in US healthcare sector | RE |
Financials (USD)
Sales 2024 * | 172B | Sales 2025 * | 182B | Capitalization | 121B |
---|---|---|---|---|---|
Net income 2024 * | 8.04B | Net income 2025 * | 9.09B | EV / Sales 2024 * | 0.81 x |
Net Debt 2024 * | 17.19B | Net Debt 2025 * | 13.67B | EV / Sales 2025 * | 0.74 x |
P/E ratio 2024 * |
15.1
x | P/E ratio 2025 * |
13.2
x | Employees | 104,900 |
Yield 2024 * |
1.2% | Yield 2025 * |
1.29% | Free-Float | 99.6% |
Latest transcript on Elevance Health, Inc.
1 day | -4.14% | ||
1 week | -3.73% | ||
Current month | -1.36% | ||
1 month | -2.95% | ||
3 months | +2.76% | ||
6 months | +9.22% | ||
Current year | +10.57% |
Managers | Title | Age | Since |
---|---|---|---|
Gail Boudreaux
CEO | Chief Executive Officer | 63 | 17-11-19 |
Mark Kaye
DFI | Director of Finance/CFO | 45 | 23-09-05 |
Ratnakar Lavu
CTO | Chief Tech/Sci/R&D Officer | 53 | Feb. 04 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 74 | 13-09-30 | |
Director/Board Member | 55 | 22-10-31 | |
Gail Boudreaux
CEO | Chief Executive Officer | 63 | 17-11-19 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
3.22% | 17 M€ | +7.83% | - | |
2.36% | 1,085 M€ | +8.85% | - | |
2.07% | 8 M€ | +4.90% |
Date | Price | Change | Volume |
---|---|---|---|
24-05-28 | 516.8 | -0.89% | 989 593 |
24-05-24 | 521.4 | -4.14% | 1,533,777 |
24-05-23 | 543.9 | -0.70% | 532,736 |
24-05-22 | 547.8 | +0.40% | 766,419 |
24-05-21 | 545.6 | +0.74% | 606,377 |
Delayed Quote Nyse, May 24, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+10.57% | 121B | |
-3.48% | 468B | |
+11.07% | 94.49B | |
-23.70% | 42.09B | |
+0.57% | 39.83B | |
-27.38% | 2.57B | |
-16.84% | 1.37B | |
+5.03% | 496M |
- Stock Market
- Equities
- ELV Stock